China Approves First Fungal Mycelium Protein as Novel Food Ingredient

China has approved its first fungal mycelium protein as a novel food ingredient, marking a milestone for the country's alternative protein sector. The green light was given to Fusarium venenatum, a high-quality protein source developed by biotech firm Fushine Bio under the brand name FuNext. The approval comes as global demand for sustainable protein alternatives continues to rise.

The National Health Commission (NHC) granted regulatory approval for FuNext alongside 13 other new food additives and ingredients. This decision aligns with China's broader food security strategy, aiming to diversify protein sources and support domestic innovation in future foods.

Fushine Bio produces FuNext through a biomass fermentation process using glucose and water as primary inputs. The ingredient is available in wet, dry, and whole-cut formats, making it versatile for applications such as meat analogues, functional nutrition products, and next-generation meat alternatives. FuNext stands out as a complete protein, containing all essential amino acids with high digestibility. It is also rich in fibre, vitamins, and minerals while being low in fat and cholesterol-free. These qualities position it as a strong candidate for high-end markets with strict protein quality requirements. The approval establishes clear national specifications, including composition limits and labelling rules for sensitive consumer groups. This regulatory framework provides a structured path for wider adoption in China's food industry. Beyond China, Fushine Bio has already self-determined FuNext as Generally Recognized as Safe (GRAS) in the US, allowing its use across various food categories. Scientists have highlighted the potential of CRISPR-based gene editing and advanced extraction techniques to further improve the protein's quality and competitiveness. Global interest in *Fusarium venenatum*-based proteins has surged since 2021, particularly in Europe and North America. The UK and Netherlands lead adoption, with Asia-Pacific markets now following as sustainability concerns and regulatory approvals drive growth.

China's approval of FuNext strengthens its position in the alternative protein market while supporting long-term food security goals. The ingredient's nutritional profile and regulatory clarity open doors for food manufacturers to develop new products. With global demand rising, the move also signals China's commitment to sustainable protein innovation.